Stay updated with breaking news from Paris Based Limflow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inari, among the area’s faster-growing public companies since going public in 2020, recently announced plans to invest a minimum of $15 million in a new manufacturing facility in Grecia, Costa Rica.
Inari Medical announced that it completed its acquisition of chronic limb-threatening ischemia (CLTI) treatment maker LimFlow.
The Inari deal comes weeks after LimFlow won FDA premarket approval for its breakthrough system to treat chronic limb-threatening ischemia.
LimFlow said new study results demonstrated statistically significant survival with its chronic limb-threatening ischemia (CLTI) treatment.